Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie Ann Francis

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Archives of Pathology & Laboratory Medicine|December 8, 2004
Gastrointestinal stromal tumor presenting as a recurrent vaginal massKatherine M Ceballos, Julie-Ann Francis, John L Mazurka
European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society|February 2, 2020
Coping with fear of cancer recurrence among ovarian cancer survivors living in small urban and rural settings: A qualitative descriptive studyJacqueline Galica, Janet Giroux, Julie-Ann Francis, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|May 22, 2017
Shannon Salvador, Stephanie Scott, Julie Ann Francis, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|May 22, 2017
No. 344-Opportunistic Salpingectomy and Other Methods of Risk Reduction for Ovarian/Fallopian Tube/Peritoneal Cancer in the General PopulationShannon Salvador, Stephanie Scott, Julie Ann Francis, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|December 25, 2018
N<sup>o</sup> 370 - Prise en charge du cancer spinocellulaire de la vulveJulie Ann Francis, Lua Eiriksson, Erin Dean, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|December 25, 2018
No. 370-Management of Squamous Cell Cancer of the VulvaJulie Ann Francis, Lua Eiriksson, Erin Dean, et al.
Future Oncology (London, England)|November 10, 2015
Current state of biomarkers in ovarian cancer prognosisKatrina K Au, Juliana A Josahkian, Julie-Ann Francis, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|May 22, 2018
Multi-omics in high-grade serous ovarian cancer: Biomarkers from genome to the immunomeCole Clifford, Natasha Vitkin, Sarah Nersesian, et al.
British Journal of Cancer|July 27, 2018
STING agonist therapy in combination with PD-1 immune checkpoint blockade enhances response to carboplatin chemotherapy in high-grade serous ovarian cancerAbdi Ghaffari, Nichole Peterson, Kasra Khalaj, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|March 18, 2021
Acceptability and Feasibility of Early Palliative Care Among Women with Advanced Epithelial Ovarian Cancer: A Randomized Controlled Pilot StudyMaria C Cusimano, Katrina Sajewycz, Ingrid Harle, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Archives of Pathology & Laboratory Medicine|December 8, 2004
Gastrointestinal stromal tumor presenting as a recurrent vaginal massKatherine M Ceballos, Julie-Ann Francis, John L Mazurka
European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society|February 2, 2020
Coping with fear of cancer recurrence among ovarian cancer survivors living in small urban and rural settings: A qualitative descriptive studyJacqueline Galica, Janet Giroux, Julie-Ann Francis, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|May 22, 2017
Shannon Salvador, Stephanie Scott, Julie Ann Francis, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|May 22, 2017
No. 344-Opportunistic Salpingectomy and Other Methods of Risk Reduction for Ovarian/Fallopian Tube/Peritoneal Cancer in the General PopulationShannon Salvador, Stephanie Scott, Julie Ann Francis, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|December 25, 2018
N<sup>o</sup> 370 - Prise en charge du cancer spinocellulaire de la vulveJulie Ann Francis, Lua Eiriksson, Erin Dean, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|December 25, 2018
No. 370-Management of Squamous Cell Cancer of the VulvaJulie Ann Francis, Lua Eiriksson, Erin Dean, et al.
Future Oncology (London, England)|November 10, 2015
Current state of biomarkers in ovarian cancer prognosisKatrina K Au, Juliana A Josahkian, Julie-Ann Francis, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|May 22, 2018
Multi-omics in high-grade serous ovarian cancer: Biomarkers from genome to the immunomeCole Clifford, Natasha Vitkin, Sarah Nersesian, et al.
British Journal of Cancer|July 27, 2018
STING agonist therapy in combination with PD-1 immune checkpoint blockade enhances response to carboplatin chemotherapy in high-grade serous ovarian cancerAbdi Ghaffari, Nichole Peterson, Kasra Khalaj, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|March 18, 2021
Acceptability and Feasibility of Early Palliative Care Among Women with Advanced Epithelial Ovarian Cancer: A Randomized Controlled Pilot StudyMaria C Cusimano, Katrina Sajewycz, Ingrid Harle, et al.
Pageof 2